I don't understand this study - where's the control treatment, and how much more effective is Zantrene than the control?
it seems it's not even testing for efficacy - only sensitivity.
That's akin to saying 'look, we've discovered that plants are sensitive to light'. So what? Does zantrene actually kill these melanoma cells or what? Compared to what? What's the control here?
Ann: Zantrene highly effective in Melanoma preclinical study, page-22
-
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |